bullish
China Healthcare Weekly (Oct.9)
216 Views13 Oct 2020 09:53
This insight summarized the important industry viewpoints, news of listed healthcare companies and capital market review for the last week of China healthcare industry.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Pre-IPO RemeGen - Insights on Two Core Products RC18 & RC4823 Oct 2020
- China Healthcare Weekly (Oct.16)19 Oct 2020
- Pre-IPO JD Health (JDH.HK) - A Better Candidate of Online Healthcare Business In China?15 Oct 2020
- China Healthcare Weekly (Oct.9)13 Oct 2020
- A Different Angle - Simcere Pharmaceutical VS Everest Medicines (01952.HK)11 Oct 2020
- Betta Pharmaceuticals (300558.SZ) - The Harvest Season Is Coming07 Oct 2020
- Autonomous Driving- Are We There Yet?20 Mar 2018
x